Journal for ImmunoTherapy of Cancer (Nov 2023)
783 Combined immunotherapy improves outcome for replication repair deficient (RRD) high-grade glioma failing anti-PD1 monotherapy: a report from the International RRD consortium
Abstract
No abstracts available.